Esperion Therapeutics Inc (ESPR) — Cash Flow-to-Debt Ratio
Esperion Therapeutics Inc (ESPR) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of $-4.29 Million could theoretically repay 0% of its total liabilities ($815.38 Million) in one year. Explore ESPR long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Esperion Therapeutics Inc Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for Esperion Therapeutics Inc across 18 annual periods. Also explore Esperion Therapeutics Inc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Esperion Therapeutics Inc (1999–2024)
Year-by-year debt coverage analysis for Esperion Therapeutics Inc. For market capitalisation and broader financial context, see how much is Esperion Therapeutics Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.03x | $-23.65 Million | $732.54 Million | ▲ +84.3% |
| 2023 | -0.21x | $-135.49 Million | $660.79 Million | ▲ +32.9% |
| 2022 | -0.31x | $-174.83 Million | $571.72 Million | ▲ +32.9% |
| 2021 | -0.46x | $-263.81 Million | $578.53 Million | ▼ -140.6% |
| 2020 | -0.19x | $-85.18 Million | $449.39 Million | ▲ +47.6% |
| 2019 | -0.36x | $-70.34 Million | $194.50 Million | ▲ +84.3% |
| 2018 | -2.31x | $-148.64 Million | $64.33 Million | ▲ +41.7% |
| 2017 | -3.96x | $-131.30 Million | $33.14 Million | ▼ -37.9% |
| 2016 | -2.87x | $-47.73 Million | $16.61 Million | ▲ +37.4% |
| 2015 | -4.59x | $-38.16 Million | $8.31 Million | ▼ -40.3% |
| 2014 | -3.27x | $-32.02 Million | $9.79 Million | ▲ +24.1% |
| 2013 | -4.31x | $-18.11 Million | $4.20 Million | ▼ -885.1% |
| 2012 | -0.44x | $-10.81 Million | $24.70 Million | ▲ +60.3% |
| 2011 | -1.10x | $-9.07 Million | $8.24 Million | ▲ +47.5% |
| 2002 | -2.10x | $-26.56 Million | $12.66 Million | ▼ -9.1% |
| 2001 | -1.92x | $-22.77 Million | $11.84 Million | ▼ -9.1% |
| 2000 | -1.76x | $-17.95 Million | $10.19 Million | ▼ -16.4% |
| 1999 | -1.51x | $-7.85 Million | $5.18 Million | — |